What are ELV's primary competitors?
Elevance Health, Inc. (formerly known as Anthem, Inc., trading under the ticker ELV) operates as a premier health benefits company in the United States, facing intense competition across managed care and health insurance sectors. Its primary corporate competitors include massive health insurance enterprises such as UnitedHealth Group, CVS Health (Aetna), Cigna Group, Humana, and Centene Corporation. These healthcare giants compete fiercely for commercial employer groups, individual consumers, Medicaid contracts, and Medicare Advantage plan enrollments by optimizing medical network coverage, premium pricing models, and digital wellness tools.
Related FAQs
Executive compensation for the chief executive leadership guiding Entain plc (a major global sports betting, gaming, and interactive entertainment enterprise) reflects international corporate governance benchmarks.
Gail Boudreaux resides in the United States, maintaining her primary household close to the corporate executive offices of Elevance Health, where she serves as the chief executive officer.
UnitedHealthcare and Anthem are both massive national insurers, and the "better" plan usually depends on the specific network available in your area.
The ticker symbol ELV historically represented Elevance Health, Inc. before its ticker transition, or relates to specific global securities.
Yes, Elevance Health is the same company as the former Anthem, Inc. The company officially rebranded from Anthem, Inc.
Elevance Health Inc. (ELV) has seen a turbulent summer, with the stock closing July 31, 2026, at $375.84. This followed a peak of over $426 in mid-July, after which the stock experienced a correction.
Deciding whether to purchase shares of Elevance Health (ELV) requires evaluating its position as a major managed healthcare provider offering health insurance plans, commercial policies, and specialized healthcare services.
Elevance Health, Inc. (ELV) equity forecasts constructed by healthcare sector analysts incorporate multi-year operational projections across managed care and commercial health insurance segments.
Yes, Elysian Bank offers a comprehensive mobile banking application that allows customers to manage their finances securely from their smartphones.
Equity research analysts tracking Elevance Health, Inc. (ELV) maintain a consensus Buy rating, with average 12-month price targets clustering around $439.22 to $443.50 per share, and upper estimates reaching up to $498.00.
Elevance Health (ELV) is currently viewed favorably by market analysts, holding a consensus rating of "Buy". This positive outlook is supported by insights from a significant number of analysts who cover the company.
Elevance Health, Inc., a massive American health insurance and managed care titan, operated for many decades under the corporate name Anthem, Inc., and prior to that as WellPoint, Inc.
Elevance Health, Inc. (ELV) operates as a leading health benefits company and independent licensee of the Blue Cross Blue Shield Association, serving tens of millions of managed care members.
Determining whether Elevance Health is a "good" investment depends on an investor’s portfolio objectives, as the stock is often viewed as a stable, large-cap utility-like play in the healthcare sector.